TLSIWTriSalus Life Sciences, Inc.vs its industry peers
A metric-by-metric comparison of TriSalus Life Sciences, Inc. against SIC 3841 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| 기업 | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| TLSIW본 종목 | $55M#8 | — | 8.5x#7 | 1.2x#4 | 53.4%#1 | -30.6%#7 | -59.7%#5 | -598.9%#7 | — | 5#1 | -61.7%#3 | — |
| SKIN | $88M#1 | — | 1.6x#3 | 0.3x#1 | -10.0%#6 | 67.4%#1 | -6.9%#1 | -17.1%#1 | — | — | -71.5%#4 | — |
| LNSR | $88M#2 | 35.8x#2 | 5.9x#6 | 1.7x#6 | 12.4%#3 | -9.2%#6 | -47.6%#3 | -230.0%#5 | — | — | — | — |
| LUNG | $85M#3 | — | 2.2x#4 | 0.9x#3 | 8.0%#5 | 4.2%#3 | -59.3%#4 | -137.8%#3 | -257.0%#3 | 3#2 | — | — |
| CVRX | $82M#4 | — | 4.1x#5 | 1.4x#5 | 10.4%#4 | 11.1%#2 | -90.5%#6 | -267.2%#6 | -296.8%#5 | 3#2 | -55.0%#2 | — |
| DRIO | $65M#5 | 1.2x#1 | 1.2x#2 | 2.9x#7 | -17.3%#7 | 2.4%#4 | -163.9%#7 | -75.7%#2 | -41.6%#1 | 3#2 | — | — |
| SKYA | $58M#6 | — | 0.4x#1 | 285.3x#8 | — | -2938.9%#8 | -132145.5%#8 | -179.6%#4 | -181.9%#2 | — | -83.3%#5 | — |
| TELA | $56M#7 | — | — | 0.7x#2 | 15.8%#2 | -2.6%#5 | -42.0%#2 | — | -257.2%#4 | 3#2 | -18.5%#1 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 3841). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. 이 표는 생성 중 시간이 초과되어 그룹의 일부만 포함합니다. 순위는 표시된 행 내에서만 유효하며 곧 채워집니다. Table built 2026-09-17.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice